Peer-influenced content. Sources you trust. No registration required. This is HCN.
MD Newsline
High-risk iFISH markers, such as CKS1B, IGH-FGFR3, and del17p, significantly affect survival outcomes in newly diagnosed multiple myeloma patients, with marked differences observed between high-risk and standard-risk cohorts.
Hematology/Oncology May 20th 2024
NEJM Evidence
Discover how the new Clonal Hematopoiesis Risk Score can help predict myeloid neoplasm risk in CHIP/CCUS patients.
Hematology/Oncology October 17th 2023
Renal & Urology News
Discover the key predictors of PSA persistence post-prostate cancer surgery and how they can inform your treatment plans and patient discussions.
Oncology, Medical October 2nd 2023
CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH